Literature DB >> 20956287

SHEP1 partners with CasL to promote marginal zone B-cell maturation.

Cecille D Browne1, Melanie M Hoefer, Suresh K Chintalapati, Matthew H Cato, Yann Wallez, Derek V Ostertag, Elena B Pasquale, Robert C Rickert.   

Abstract

The marginal zone is a cellular niche bordering the marginal sinus of the spleen that contains specialized B-cell and macrophage subsets poised to capture bloodborne antigens. Marginal zone B cells are retained in this niche by integrin-mediated signaling induced by G protein-coupled receptors (GPCRs) and, likely, the B-cell receptor (BCR). Sphingosine-1-phosphate (S1P) signaling via the S1P family of GPCRs is known to be essential for B-cell localization in the marginal zone, but little is known about the downstream signaling events involved. Here, we demonstrate that the adaptor protein SHEP1 is required for marginal zone B-cell maturation. SHEP1 functions in concert with the scaffolding protein CasL, because we show that SHEP1 and CasL are constitutively associated in B cells. SHEP1 association is required for the BCR or S1P receptor(s) to induce the conversion of CasL into its serine/threonine hyperphosphorylated form, which is important for lymphocyte adhesion and motility. Thus, SHEP1 orchestrates marginal zone B-cell movement and retention as a key downstream effector of the BCR and S1P receptors.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20956287      PMCID: PMC2973925          DOI: 10.1073/pnas.1007558107

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  42 in total

1.  Integrin-mediated long-term B cell retention in the splenic marginal zone.

Authors:  Theresa T Lu; Jason G Cyster
Journal:  Science       Date:  2002-07-19       Impact factor: 47.728

2.  A novel signaling intermediate, SHEP1, directly couples Eph receptors to R-Ras and Rap1A.

Authors:  V C Dodelet; C Pazzagli; A H Zisch; C A Hauser; E B Pasquale
Journal:  J Biol Chem       Date:  1999-11-05       Impact factor: 5.157

3.  Focal adhesion kinase regulates beta1 integrin-dependent T cell migration through an HEF1 effector pathway.

Authors:  G A van Seventer; H J Salmen; S F Law; G M O'Neill; M M Mullen; A M Franz; S B Kanner; E A Golemis; J M van Seventer
Journal:  Eur J Immunol       Date:  2001-05       Impact factor: 5.532

4.  Haematopoietic cell-specific CDM family protein DOCK2 is essential for lymphocyte migration.

Authors:  Y Fukui; O Hashimoto; T Sanui; T Oono; H Koga; M Abe; A Inayoshi; M Noda; M Oike; T Shirai; T Sasazuki
Journal:  Nature       Date:  2001-08-23       Impact factor: 49.962

5.  Marginal zone B cells transport and deposit IgM-containing immune complexes onto follicular dendritic cells.

Authors:  Andrew R Ferguson; Michele E Youd; Ronald B Corley
Journal:  Int Immunol       Date:  2004-08-23       Impact factor: 4.823

6.  SHEP1 function in cell migration is impaired by a single amino acid mutation that disrupts association with the scaffolding protein cas but not with Ras GTPases.

Authors:  Monique Dail; Matthew S Kalo; Jaime A Seddon; Jean-François Côté; Kristiina Vuori; Elena B Pasquale
Journal:  J Biol Chem       Date:  2004-07-22       Impact factor: 5.157

7.  Sphingosine 1-phosphate receptor 1 promotes B cell localization in the splenic marginal zone.

Authors:  Guy Cinamon; Mehrdad Matloubian; Matthew J Lesneski; Ying Xu; Caroline Low; Theresa Lu; Richard L Proia; Jason G Cyster
Journal:  Nat Immunol       Date:  2004-06-06       Impact factor: 25.606

8.  Regulation of HEF1 expression and phosphorylation by TGF-beta 1 and cell adhesion.

Authors:  Mingzhe Zheng; Paula J McKeown-Longo
Journal:  J Biol Chem       Date:  2002-08-19       Impact factor: 5.157

9.  DOCK2 associates with CrkL and regulates Rac1 in human leukemia cell lines.

Authors:  Hiroshi Nishihara; Masae Maeda; Atsushi Oda; Masumi Tsuda; Hirofumi Sawa; Kazuo Nagashima; Shinya Tanaka
Journal:  Blood       Date:  2002-06-28       Impact factor: 22.113

10.  Integrin-dependence of lymphocyte entry into the splenic white pulp.

Authors:  Charles G Lo; Theresa T Lu; Jason G Cyster
Journal:  J Exp Med       Date:  2003-02-03       Impact factor: 14.307

View more
  7 in total

Review 1.  Cytoskeletal control of B cell responses to antigens.

Authors:  Pavel Tolar
Journal:  Nat Rev Immunol       Date:  2017-07-10       Impact factor: 53.106

2.  Monocyte Adhesion and Plaque Recruitment During Atherosclerosis Development Is Regulated by the Adapter Protein Chat-H/SHEP1.

Authors:  Olivier Herbin; Adam G Regelmann; Bhama Ramkhelawon; Erica G Weinstein; Kathryn J Moore; Konstantina Alexandropoulos
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-07-14       Impact factor: 8.311

3.  Association of the breast cancer antiestrogen resistance protein 1 (BCAR1) and BCAR3 scaffolding proteins in cell signaling and antiestrogen resistance.

Authors:  Yann Wallez; Stefan J Riedl; Elena B Pasquale
Journal:  J Biol Chem       Date:  2014-02-28       Impact factor: 5.157

4.  NSP-CAS Protein Complexes: Emerging Signaling Modules in Cancer.

Authors:  Yann Wallez; Peter D Mace; Elena B Pasquale; Stefan J Riedl
Journal:  Genes Cancer       Date:  2012-05

5.  NSP-Cas protein structures reveal a promiscuous interaction module in cell signaling.

Authors:  Peter D Mace; Yann Wallez; Małgorzata K Dobaczewska; Jeongeun J Lee; Howard Robinson; Elena B Pasquale; Stefan J Riedl
Journal:  Nat Struct Mol Biol       Date:  2011-11-13       Impact factor: 15.369

6.  The scaffold protein NEDD9 is necessary for leukemia-cell migration and disease progression in a mouse model of chronic lymphocytic leukemia.

Authors:  Phuong-Hien Nguyen; Tamina Seeger-Nukpezah; Lisa Rusyn; Sebastian Reinartz; Anastasia Nikiforov; Nelly Mikhael; Alexander Vom Stein; Viktoria Kohlhas; Johannes Bloehdorn; Stephan Stilgenbauer; Philipp Lohneis; Reinhard Buettner; Sandra Robrecht; Kirsten Fischer; Christian Pallasch; Michael Hallek
Journal:  Leukemia       Date:  2022-05-06       Impact factor: 12.883

7.  IGF1R signalling is a guardian of self-tolerance restricting autoantibody production.

Authors:  Malin C Erlandsson; Seval Erdogan; Caroline Wasén; Karin M E Andersson; Sofia T Silfverswärd; Rille Pullerits; Mats Bemark; Maria I Bokarewa
Journal:  Front Immunol       Date:  2022-08-29       Impact factor: 8.786

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.